The Nutshell

» genetics & genomics, culture and disease/medicine

Daily News Roundup

Most Recent

image: Study Raises Questions About Patient-Derived Xenografts

Study Raises Questions About Patient-Derived Xenografts

By | October 10, 2017

When transplanted into mice, tumor genomes evolve differently than they do in patients, study finds.

1 Comment

image: Gene Drive Limitations

Gene Drive Limitations

By | October 9, 2017

In lab populations of genetically engineered mosquitoes, mutations arose that blocked the gene drive’s spread and restored female fertility.

0 Comments

Tissue recipients were treated as “guinea pigs,” says investigation leader.

0 Comments

Researchers use base-editing to swap out an erroneous nucleotide responsible for a potentially life-threatening blood disorder.

0 Comments

image: Enormous University Gift Raises Questions over Donor Influence

Enormous University Gift Raises Questions over Donor Influence

By | September 26, 2017

The donation to the University of California, Irvine, is slated to fund a new college focusing on what some critics call pseudoscience and quackery.

9 Comments

image: Most Accurate CRISPR Gene Editing Yet

Most Accurate CRISPR Gene Editing Yet

By | September 22, 2017

A tweaked Cas9 nuclease reduces off-target effects to levels below that of previous versions of the enzyme.

0 Comments

image: CRISPR Used in Human Embryos to Probe Gene Function

CRISPR Used in Human Embryos to Probe Gene Function

By | September 20, 2017

OCT4 is necessary for blastocyst formation in the human embryo, researchers report.

0 Comments

image: Criticism for Craig Venter’s “Face-Prediction” Software

Criticism for Craig Venter’s “Face-Prediction” Software

By | September 11, 2017

The tool cannot predict a person’s face from DNA, say researchers—including some listed as coauthors on the publication. 

1 Comment

image: How Exercise Might Fight Cancer

How Exercise Might Fight Cancer

By | September 8, 2017

Epinephrine’s activation of the signaling pathway Hippo is responsible for the in vitro tumor-fighting effects of serum from women who worked out.

0 Comments

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech